SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-081108
Filing Date
2023-09-29
Accepted
2023-09-29 17:18:28
Documents
15
Period of Report
2023-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186106-8k_inmedpharm.htm   iXBRL 8-K 35388
2 NEWS RELEASE, DATED SEPTEMBER 29, 2023 ea186106ex99-1inmedpharm.htm EX-99.1 106467
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-23-081108.txt   379647

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20230929.xsd EX-101.SCH 3265
5 XBRL DEFINITION FILE inm-20230929_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20230929_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20230929_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea186106-8k_inmedpharm_htm.xml XML 4020
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 231296697
SIC: 2834 Pharmaceutical Preparations